![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TOXICOLOGY
(PPAR
)-Regulated Genes and Is Ameliorated by PPAR
Activation
Department of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania (A.A.N.); Department of Medicine, Weill Medical College of Cornell University and Nutrition Center at Strang Cancer Prevention Center, New York, New York (A.J.D.); Research Unit of Alcohol Diseases, Helsinki University Central Hospital, Helsinki, Finland (K.J.); and Department of Medicine, University of California, San Francisco, California (N.M.B.)
Alcoholic liver disease is associated with a state of hepatic fatty acid overload. We examined the effect of ethanol and different types of dietary fat on the expression of mRNA for liver fatty acid binding protein (L-FABP), peroxisome proliferator-activated receptor-
(PPAR
), and peroxisomal fatty acyl CoA oxidase (FACO). Four groups of rats (n = 5) were fed intragastrically, a liquid diet with or without ethanol (1016 g/kg/day) for 4 weeks. Pair-fed controls received isocaloric amounts of dextrose. The source of fat was either corn oil or fish oil. Ethanolfed rats developed fatty liver, necrosis, and inflammation; the changes were more severe in the fish oil-ethanol (FE) rats. PPAR
mRNA levels were not different between groups, although there was a trend toward increased levels in ethanol-fed rats. We calculated L-FABP/PPAR
and FACO/PPAR
ratios as a measure of FACO and L-FABP up-regulation relative to PPAR
expression. Both FACO/PPAR
and L-FABP/PPAR
ratios were significantly decreased in FE rats. However, only L-FABP/PPAR
was decreased in corn oil plus ethanol rats. Also, the level of L-FABP/mRNA correlated inversely with the degree of fatty liver in ethanol-fed rats. Since expression of PPAR
response genes was impaired in ethanol-fed rats, we determined whether activation of PPAR
would normalize the PPAR
response and prevent the pathological changes in ethanol-fed rats. Treatment with clofibrate, a PPAR
-activating ligand, led to a marked decrease in fatty liver and complete abrogation of necroinflammatory changes in FE rats. Also, nuclear factor
B activation and up-regulation of tumor necrosis factor-
and cyclooxygenase-2 was also abolished in clofibrate-treated rats. We conclude that adaptive gene regulation of FACO and L-FABP by PPAR
is impaired in ethanol-fed rats and that treatment with clofibrate, a PPAR
ligand, prevents alcohol-induced pathological liver injury, possibly by reversing the above changes.
Address correspondence to: Dr. Amin A. Nanji, Department of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, 3400 Spruce Street, Founders 7.103, Philadelphia, PA 19104-4283. E-mail: amin.nanji{at}uphs.upenn.edu
This article has been cited by other articles:
![]() |
M. Sozio and D. W. Crabb Alcohol and lipid metabolism Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E10 - E16. [Abstract] [Full Text] [PDF] |
||||